Fortrea Holdings (FTRE) Other Operating Expenses (2022 - 2026)

Fortrea Holdings (FTRE) reported Other Operating Expenses of $539.4 million for Q1 2026, down 48.61% on a YoY basis from $1.0 billion in Q1 2025, and down 5.55% quarter-over-quarter from $571.1 million in Q4 2025.

Fortrea Holdings (FTRE) Other Operating Expenses (2022 - 2026) Analysis & Trends

Fortrea Holdings has reported Other Operating Expenses for 5 years, with the latest figure at $539.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Operating Expenses fell 48.61% year-over-year to $539.4 million; the trailing twelve-month figure through Mar 2026 stood at $2.6 billion (down 5.0% YoY), and the FY2025 full-year result was $3.1 billion, up 37.25% from the prior year.
  • Other Operating Expenses for Q1 2026 stood at $539.4 million, down from $571.1 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $1.0 billion in Q1 2025, with the low at $286.0 million in Q4 2022.
  • Historically, Other Operating Expenses has averaged $616.1 million across 5 years, with a median of $588.4 million in 2023.
  • Annual changes were most pronounced in 2023 — Other Operating Expenses jumped 109.58% — and 2026, when it slumped 48.61%.
  • Fortrea Holdings' Other Operating Expenses stood at $286.0 million in 2022, then soared by 109.58% to $599.4 million in 2023, then gained by 0.85% to $604.5 million in 2024, then dropped by 5.53% to $571.1 million in 2025, then decreased by 5.55% to $539.4 million in 2026.
  • The last three Other Operating Expenses figures came in at $539.4 million (Q1 2026), $571.1 million (Q4 2025), and $603.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 539.40 Mn
Dec 31, 2025 571.10 Mn
Sep 30, 2025 603.10 Mn
Jun 30, 2025 915.80 Mn
Mar 31, 2025 1.05 Bn
Dec 31, 2024 604.50 Mn
Sep 30, 2024 556.60 Mn
Jun 30, 2024 557.10 Mn
Mar 31, 2024 579.40 Mn
Dec 31, 2023 599.40 Mn
Sep 30, 2023 585.10 Mn
Jun 30, 2023 591.80 Mn
Mar 31, 2023 563.00 Mn
Dec 31, 2022 286.00 Mn
Sep 30, 2022 617.50 Mn
Jun 30, 2022 637.70 Mn